Berodual Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per mL Ipratropium Br 250 mcg, fenoterol HBr 500 mcg

Indications/Uses

Bronchodilator for symptomatic prevention & treatment of chronic obstructive airway disorders w/ reversible airflow limitation eg, bronchial asthma & especially chronic bronchitis w/ or w/o emphysema, consider concomitant anti-inflammatory therapy in patients w/ bronchial asthma & steroid-responsive COPD.

Click to view Berodual detailed prescribing information

Dosage/Direction for Use

Adult including elderly & adolescent >12 yr Acute bronchospasm 1-2.5 mL (20-50 drops). Severe cases 4 mL (80 drops). Acute asthma Childn 6-12 yr 0.5-2 mL (10-40 drops), <6 yr, <22 kg 0.1 mL/kg (2 drops). Max: 0.5 mL (10 drops).

Click to view Berodual detailed prescribing information

Overdosage

View Berodual overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to fenoterol HBr or atropine-like substances. Hypertrophic obstructive cardiomyopathy & tachyarrhythmia.

Click to view Berodual detailed prescribing information

Special Precautions

Hypersensitivity. Discontinue use if paradoxical bronchospasm occurs. Patients predisposed to narrow-angle glaucoma. Insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism, phaeochromocytoma, preexisting urinary tract obstruction eg, prostatic hyperplasia or bladder-neck obstruction; underlying severe heart disease eg, ischaemic heart disease, arrhythmia or severe heart failure; hypokalaemia; cystic fibrosis; acute, rapidly worsening dyspnoea. Avoid contact w/ eyes. Positive doping test result. Prolonged use. Concomitant use w/ other sympathomimetic bronchodilators. May cause wheezing & breathing difficulties due to benzalkonium Cl. May affect ability to drive & use machines. Pregnancy & lactation.

Click to view Berodual detailed prescribing information

Use In Pregnancy & Lactation

Click to view Berodual detailed prescribing information

Adverse Reactions

Cough, dry mouth, headache, tremor, pharyngitis, nausea, dizziness, dysphonia, tachycardia, palpitations, vomiting, increased heart rate & systolic BP, nervousness.

Drug Interactions

Enhanced bronchodilatory effect w/ other β-adrenergics, anticholinergics, xanthine derivatives eg, theophylline. Potentially serious reduced bronchodilation w/ β-blockers. Increased β₂-agonist-induced hypokalaemia w/ xanthine derivatives, corticosteroids, diuretics. Increased susceptibility to arrhythmias w/ digoxin. Enhanced action w/ MAOIs or TCAs. Increased susceptibility on CV effects w/ halogenated hydrocarbon anaesth inhalation eg, halothane, trichloroethylene & enflurane. Not recommended in co-administration w/ other anticholinergic drugs.

Click to view Berodual detailed prescribing information

Storage

View Berodual storage conditions for details to ensure optimal shelf-life.

Description

View Berodual description for details of the chemical structure and excipients (inactive components).

Action

View Berodual mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AL01 - fenoterol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Berodual inhalation soln

Packing/Price

20 mL x 1's

Berodual

ipratropium + fenoterol

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH